Get started
Author

Theresa Ruf

Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
2023 · Charlotte Fenioux, Baptiste Abbar, et al. · Nature Medicine · 82
Immune checkpoint inhibitor-associated myocarditis: a novel risk score
2025 · John R Power, Charles Dolladille, et al. · European Heart Journal · 76
PDF
Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors
2024 · Theresa Ruf, Rafaela Kramer, et al. · European Journal of Cancer · 58
PDF
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
2023 · Dirk Tomsitz, Theresa Ruf, et al. · Cancers · 40
PDF
Comprehensive plasma and tissue profiling reveals systemic metabolic alterations in cardiac hypertrophy and failure
2018 · Oliver J Müller, Markus B Heckmann, et al. · Cardiovascular Research · 39
Tebentafusp in Patients with Metastatic Uveal Melanoma: A Real-Life Retrospective Multicenter Study
2023 · Dirk Tomsitz, Theresa Ruf, et al. · Cancers · 26
PDF
AAV-mediated expression of NFAT decoy oligonucleotides protects from cardiac hypertrophy and heart failure
2021 · Anca Remes, Andreas H. Wagner, et al. · Basic Research in Cardiology · 23
PDF
The side effect registry immuno-oncology (SERIO) – A tool for systematic analysis of immunotherapy-induced side effects
2023 · Carolin Ertl, Carolin Ertl, et al. · European Journal of Cancer · 18
AAV-mediated overexpression of CPT1B protects from cardiac hypertrophy and heart failure in a murine pressure overload model
2025 · Anca Kliesow Remes, Theresa Ruf, et al. · Basic Research in Cardiology · 13
PDF
Extracorporeal Photopheresis as a Treatment Option for Immune-Related Adverse Events: Two Case Reports and a Prospective Study
2024 · Theresa Ruf, Farnaz Rahimi, et al. · Journal of Immunotherapy · 11
Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
2024 · Charlotte Fenioux, Baptiste Abbar, et al. · Nature Medicine · 3
PDF
Tumor Lysis Syndrome Induced by Tebentafusp
2023 · Theresa Ruf, Anna Leonhardt, et al. · Immunotherapy · 2
Extracorporeal photopheresis versus systemic immunosuppression for treatment of immune-related adverse events: clinical outcomes from the prospective two-arm PRIA study
2026 · Lisa Wein, Carolin Ertl, et al. · Journal for ImmunoTherapy of Cancer · 1
Alopecia areata incognita – die Tosti-Alopezie
2026 · Christina Schmitt, Theresa Ruf, et al. · Die Dermatologie
Therapierefraktärer Lichen ruber exanthematicus
2026 · Marius Winkler, Theresa Ruf, et al. · Die Dermatologie
Abstract LB421: Extracorporeal photopheresis vs. systemic immunosuppression for treatment of immune-related adverse events: Final analysis of the prospective two-arm PRIA study
2026 · Lisa Wein, Carolin Ertl, et al. · Cancer Research
Correction to: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis (Nature Medicine, (2023), 29, 12, (3100-3110), 10.1038/s41591-023-02591-2)
2024 · Fenioux, Charlotte, Abbar, Baptiste, et al. · Institutional Repositories DataBase (IRDB)
Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
2023 · Charlotte Fenioux, Baptiste Abbar, et al. · Nature Medicine
PDF
Second-Line Immunosuppressants in Steroid-Refractory Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors
2023 · Dirk Tomsitz, Theresa Ruf, et al. · SSRN Electronic Journal
P3760Comprehensive fingerprints of plasma, heart, liver, and muscle tissue disclose systemic metabolic alterations in cardiac hypertrophy and heart failure
2018 · O J Mueller, M H Heckmann, et al. · European Heart Journal
PDF
P4776Targeting metabolic remodeling in a murine heart failure model by AAV-mediated over-expression of organic cation/carnitine transporter 2 (OCTN2)
2018 · L Ding, M H Heckmann, et al. · European Heart Journal
Works count: 24
Citation count: 410
H-index: 11
I10-index: 11
Year
Topic
Type